Cargando…

Tumor metabolic reprogramming in lung cancer progression

Metabolic reprogramming is an important characteristic of tumor cells. Tumor cells reprogram their metabolic pathways to meet the material, energy and redox force needs for rapid proliferation. Metabolic reprogramming changes the level or type of specific metabolites inside and outside cells, and pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xin, Liu, Minghui, Liu, Hongyu, Chen, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260716/ https://www.ncbi.nlm.nih.gov/pubmed/35814833 http://dx.doi.org/10.3892/ol.2022.13407

Ejemplares similares

Linking Metabolic Reprogramming, Plasticity and Tumor Progression
por: Shuvalov, Oleg, et al.
Publicado: (2021)

Metabolic Reprogramming of Cancer Cells during Tumor Progression and Metastasis
por: Ohshima, Kenji, et al.
Publicado: (2021)

Editorial: Metabolic reprogramming and cancer progression
por: Yin, Qinan, et al.
Publicado: (2022)

Tumor Metabolic Reprogramming by Adipokines as a Critical Driver of Obesity-Associated Cancer Progression
por: Pham, Duc-Vinh, et al.
Publicado: (2021)

Targeting Hypoxia-Driven Metabolic Reprogramming to Constrain Tumor Progression and Metastasis
por: Miranda-Galvis, Marisol, et al.
Publicado: (2020)

Functional polarization of tumor-associated macrophages dictated by metabolic reprogramming
por: Zeng, Wentao, et al.
Publicado: (2023)

Germline EGFR mutations in lung cancer (Review)
por: Liu, Minghui, et al.
Publicado: (2023)

Role of Glucose Metabolic Reprogramming in Breast Cancer Progression and Drug Resistance
por: Lei, Pan, et al.
Publicado: (2023)

Clinical study of apatinib combined with EGFR‐TKI in the treatment of chronic progression after EGFR‐TKI treatment in non‐small cell lung cancer (ChiCTR1800019185)
por: Li, Xin, et al.
Publicado: (2020)

Oncofetal reprogramming in tumor development and progression: novel insights into cancer therapy
por: Cao, Jiangjun, et al.
Publicado: (2023)

Metabolic Reprogramming in Tumor Endothelial Cells
por: García-Caballero, Melissa, et al.
Publicado: (2022)

Oncogenic regulation of tumor metabolic reprogramming
por: Tarrado-Castellarnau, Míriam, et al.
Publicado: (2016)

Harnessing Metabolic Reprogramming to Improve Cancer Immunotherapy
por: Yan, Liang, et al.
Publicado: (2021)

The Metabolism Reprogramming of microRNA Let-7-Mediated Glycolysis Contributes to Autophagy and Tumor Progression
por: Li, Chien-Hsiu, et al.
Publicado: (2021)

Serine Metabolic Reprogramming in Tumorigenesis, Tumor Immunity, and Clinical Treatment
por: Shunxi, Wang, et al.
Publicado: (2023)

Recent Analytical Advances for Decoding Metabolic Reprogramming in Lung Cancer
por: Almalki, Atiah H.
Publicado: (2023)

Impacts and mechanisms of metabolic reprogramming of tumor microenvironment for immunotherapy in gastric cancer
por: Zhao, Lin, et al.
Publicado: (2022)

Exosomal cargos-mediated metabolic reprogramming in tumor microenvironment
por: Tan, Shiming, et al.
Publicado: (2023)

Exosome-mediated metabolic reprogramming: the emerging role in tumor microenvironment remodeling and its influence on cancer progression
por: Yang, Enli, et al.
Publicado: (2020)

On metabolic reprogramming and tumor biology: A comprehensive survey of metabolism in breast cancer
por: Penkert, Judith, et al.
Publicado: (2016)

Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospects
por: Shang, Run-Ze, et al.
Publicado: (2016)

Hypoxia-induced GBE1 expression promotes tumor progression through metabolic reprogramming in lung adenocarcinoma
por: Li, Lifeng, et al.
Publicado: (2020)

Overexpression of lncRNA IGFBP4–1 reprograms energy metabolism to promote lung cancer progression
por: Yang, Binyao, et al.
Publicado: (2017)

Succinate dehydrogenase 5 regulates lung cancer metastasis by reprogramming glucose metabolism
por: Li, Jie, et al.
Publicado: (2021)

LINE-1 promotes tumorigenicity and exacerbates tumor progression via stimulating metabolism reprogramming in non-small cell lung cancer
por: Sun, Zeguo, et al.
Publicado: (2022)

Metabolic reprogramming in the immunosuppression of tumor-associated macrophages
por: Wang, Ying, et al.
Publicado: (2022)

Metabolic reprogramming of cancer-associated fibroblasts and its effect on cancer cell reprogramming
por: Li, Zhenzhen, et al.
Publicado: (2021)

The role of Wnt signaling pathway in tumor metabolic reprogramming
por: Mo, Yongzhen, et al.
Publicado: (2019)

Lactylation, an emerging hallmark of metabolic reprogramming: Current progress and open challenges
por: Liu, Xuelian, et al.
Publicado: (2022)

The role of lipid metabolic reprogramming in tumor microenvironment
por: Yang, Kai, et al.
Publicado: (2023)

Fatty Acid Metabolism Reprogramming in Advanced Prostate Cancer
por: Xu, Huan, et al.
Publicado: (2021)

Nrf2-Mediated Metabolic Reprogramming in Cancer
por: Wang, Yan-Yang, et al.
Publicado: (2018)

Lipid metabolism reprogramming in tumor-associated macrophages and implications for therapy
por: Qiao, Xuehan, et al.
Publicado: (2023)

Autophagy and Glycometabolic Reprograming in the Malignant Progression of Lung Cancer: A Review
por: Li, Yuting, et al.
Publicado: (2023)

Therapeutic Potential of Tumor Metabolic Reprogramming in Triple-Negative Breast Cancer
por: Munkácsy, Gyöngyi, et al.
Publicado: (2023)

Metabolic Reprogramming in Tumor-Associated Macrophages in the Ovarian Tumor Microenvironment
por: Kumar, Sudhir, et al.
Publicado: (2022)

Immune cell metabolism and metabolic reprogramming
por: Hu, Chenchen, et al.
Publicado: (2022)

Epigenetic Reprogramming of Tumor-Associated Fibroblasts in Lung Cancer: Therapeutic Opportunities
por: Alcaraz, Jordi, et al.
Publicado: (2021)

Lipid metabolic Reprogramming: Role in Melanoma Progression and Therapeutic Perspectives
por: Pellerin, Laurence, et al.
Publicado: (2020)

Research progress of circRNA in malignant tumour metabolic reprogramming
por: Geng, Yikun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8ftrsatvk9phrqc0sre9o0e9ua